Showing results (1-10 of 213) with videos related to
Sort By:
Pageof 22
Cancer Letters|December 3, 2014
De novo hepatocellular carcinoma of liver allograft: a neglected issueFranco Trevisani, Francesca Garuti, Alessandro Cucchetti, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 11, 2012
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosisFranco Trevisani, Antonio Di Micoli, Andrea Zambruni, et al.Annals of Hepatology|October 24, 2021
The ITA.LI.CA Consortium: How multicentre collaboration helped shape the management of patients with hepatocellular carcinoma on the basis of real-world evidenceFranco Trevisani, Edoardo G Giannini, Biomedicines|May 16, 2023
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or ResistanceFilippo Pelizzaro, Fabio Farinati, Franco TrevisaniHepatology (Baltimore, Md.)|September 20, 2014
Prognosis of untreated hepatocellular carcinomaEdoardo G Giannini, Fabio Farinati, Francesca Ciccarese, et al.Recenti Progressi in Medicina|February 17, 2018
[Personalized healthcare in hepatocellular carcinoma. Multi-society Italian position paper.]Franco Trevisani, Francesca Garuti, Andrea NeriSeminars in Liver Disease|March 9, 2019
Alpha-fetoprotein for Diagnosis, Prognosis, and Transplant SelectionFranco Trevisani, Francesca Garuti, Andrea NeriLiver Cancer|August 8, 2024
Surveillance for Hepatocellular Carcinoma in Patients with Successfully Treated Viral Disease of the Liver: A Systematic ReviewLorenzo Lani, Benedetta Stefanini, Franco TrevisaniVaccines|October 7, 2020
Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?Francesco Tovoli, Stefania De Lorenzo, Franco TrevisaniCancers|October 14, 2022
Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular CarcinomaStefania De Lorenzo, Francesco Tovoli, Franco TrevisaniPageof 22